A Secondary Analysis of the Atherosclerosis Prevention in Pediatric Lupus Erythematosus (APPLE) Study Shows That Atorvastatin Therapy Reduces Progression of Carotid Intima Medial Thickening in Pubertal SLE Patients with Higher C Reactive Protein
Publication
, Conference
Ardoin, SP; Schanberg, LE; Sandborg, CI; Barnhart, H; Yow, E; Evans, G; Mieszkalski, K; Ilowite, NT; von Scheven, E; Eberhard, BA; Imundo, LF ...
Published in: ARTHRITIS AND RHEUMATISM
October 1, 2011
Duke Scholars
Published In
ARTHRITIS AND RHEUMATISM
ISSN
0004-3591
Publication Date
October 1, 2011
Volume
63
Issue
10
Start / End Page
S784 / S785
Location
Chicago, IL
Publisher
WILEY-BLACKWELL
Conference Name
75th Annual Scientific Meeting of the American-College-of-Rheumatology/46th Annual Scientific Meeting of the Association-of-Rheumatology-Health-Professionals
Related Subject Headings
- Arthritis & Rheumatology
- 1117 Public Health and Health Services
- 1107 Immunology
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Ardoin, S. P., Schanberg, L. E., Sandborg, C. I., Barnhart, H., Yow, E., Evans, G., … Brunner, H. (2011). A Secondary Analysis of the Atherosclerosis Prevention in Pediatric Lupus Erythematosus (APPLE) Study Shows That Atorvastatin Therapy Reduces Progression of Carotid Intima Medial Thickening in Pubertal SLE Patients with Higher C Reactive Protein. In ARTHRITIS AND RHEUMATISM (Vol. 63, pp. S784–S785). Chicago, IL: WILEY-BLACKWELL.
Ardoin, Stacy P., Laura E. Schanberg, Christy I. Sandborg, Huiman Barnhart, Eric Yow, Greg Evans, Kelly Mieszkalski, et al. “A Secondary Analysis of the Atherosclerosis Prevention in Pediatric Lupus Erythematosus (APPLE) Study Shows That Atorvastatin Therapy Reduces Progression of Carotid Intima Medial Thickening in Pubertal SLE Patients with Higher C Reactive Protein.” In ARTHRITIS AND RHEUMATISM, 63:S784–85. WILEY-BLACKWELL, 2011.
Ardoin SP, Schanberg LE, Sandborg CI, Barnhart H, Yow E, Evans G, et al. A Secondary Analysis of the Atherosclerosis Prevention in Pediatric Lupus Erythematosus (APPLE) Study Shows That Atorvastatin Therapy Reduces Progression of Carotid Intima Medial Thickening in Pubertal SLE Patients with Higher C Reactive Protein. In: ARTHRITIS AND RHEUMATISM. WILEY-BLACKWELL; 2011. p. S784–5.
Ardoin, Stacy P., et al. “A Secondary Analysis of the Atherosclerosis Prevention in Pediatric Lupus Erythematosus (APPLE) Study Shows That Atorvastatin Therapy Reduces Progression of Carotid Intima Medial Thickening in Pubertal SLE Patients with Higher C Reactive Protein.” ARTHRITIS AND RHEUMATISM, vol. 63, no. 10, WILEY-BLACKWELL, 2011, pp. S784–85.
Ardoin SP, Schanberg LE, Sandborg CI, Barnhart H, Yow E, Evans G, Mieszkalski K, Ilowite NT, von Scheven E, Eberhard BA, Imundo LF, Levy DM, Kimura Y, Silverman ED, Bowyer SL, Punaro MG, Singer NG, Sherry DD, McCurdy DK, Klein-Gitelman M, Wallace CA, Silver RM, Wagner-Weiner L, Higgins G, Brunner H. A Secondary Analysis of the Atherosclerosis Prevention in Pediatric Lupus Erythematosus (APPLE) Study Shows That Atorvastatin Therapy Reduces Progression of Carotid Intima Medial Thickening in Pubertal SLE Patients with Higher C Reactive Protein. ARTHRITIS AND RHEUMATISM. WILEY-BLACKWELL; 2011. p. S784–S785.
Published In
ARTHRITIS AND RHEUMATISM
ISSN
0004-3591
Publication Date
October 1, 2011
Volume
63
Issue
10
Start / End Page
S784 / S785
Location
Chicago, IL
Publisher
WILEY-BLACKWELL
Conference Name
75th Annual Scientific Meeting of the American-College-of-Rheumatology/46th Annual Scientific Meeting of the Association-of-Rheumatology-Health-Professionals
Related Subject Headings
- Arthritis & Rheumatology
- 1117 Public Health and Health Services
- 1107 Immunology
- 1103 Clinical Sciences